Clinical trials
Lung clinical trials
Below are recruiting lung clinical trials, each written for real people, not researchers. We’re tracking 2,833 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04537182Recruiting
Surgery versus bronchoscopy for severe emphysema
This study compares two ways to reduce lung “overinflation” in people with severe emphysema: surgery (LVRS) or a bronchoscopy procedure (BLVR). It aims to see which approach works best and is safest for eligible patients.
ViennaAges 30–80 - NCT07843940RecruitingPhase 1/Phase 2
Two study drugs for extensive-stage small cell lung cancer
This trial tests two new immunotherapy drugs (obrixtamig and pumitamig) given together for people with extensive-stage small cell lung cancer. The goal is to see if the combination is safe and helps shrink or control the cancer.
Miami, FloridaAges 18 years+ - NCT03979170Recruiting
Test lung cancer drug response using patient tumor mini-organs
This trial grows “organoids” (mini tumor models) from your lung cancer tissue to see which drug responses are most likely. It may help match future treatments to how your tumor behaves in the lab.
GenevaAges 18 years+ - NCT07837128Recruiting
Gentle breathing support in intensive care
This trial tests two ways of using a breathing machine (ventilator) in the ICU. One method is more gentle on the lungs, and the goal is to see if it helps patients recover faster.
Amsterdam, NLAges 18 years+ - NCT03562052Recruiting
Lung cancer screening for high-risk workers and smokers
This study offers lung cancer screening (using scans) for people at high risk due to smoking history and workplace exposure to cancer-causing substances. It aims to find lung cancers earlier and understand who benefits most from regular screening.
BordeauxAges 55–74 - NCT06492421RecruitingPhase 2
Immunotherapy before surgery for lung cancer
This trial tests whether giving two immunotherapy drugs directly into the tumor before surgery can shrink non-small cell lung cancer and improve outcomes. It is for people with early-stage (IIIA) lung cancer who are candidates for surgery.
Guanzhou, GuangdongAges 18–75 - NCT07790614Recruiting
Comparing two CT scan methods for identifying pulmonary fibrosis
This study compares two types of CT scans to see which one is better at identifying idiopathic pulmonary fibrosis (IPF), a specific type of interstitial lung disease. You may be able to join if you have been diagnosed with ILD and are being discussed by a team of specialists.
Rozzano, ItalyAges 18 years+ - NCT07784959RecruitingPhase 1
Study of NXP900 with lorlatinib for ALK-positive lung cancer
This study tests a new drug called NXP900 in combination with lorlatinib for people with ALK-positive lung cancer who have already been treated with lorlatinib and tolerated it well. The goal is to see if this combination is safe and effective.
Fairfax, VirginiaAges Any age - NCT07776353Recruiting
Understanding weight loss in advanced cancer
This study looks at how weight loss and muscle loss affect people with advanced cancer. It aims to find different types of weight loss to better guide treatment and care.
Pleasanton, CaliforniaAges 18 years+ - NCT07761351RecruitingPhase 4
Robotic-assisted vs CT-guided lung biopsy comparison
This study compares two ways to biopsy small lung nodules: a robot-assisted scope through the airways or a needle guided by CT scan. If you have a small lung nodule (2 cm or less) that needs testing, participation may help determine which approach is better.
HeidelbergAges 18 years+ - NCT07761910RecruitingPhase 2
Study of heart effects of radiation therapy using PET-CT for stage III lung cancer
This study looks at whether PET-CT scans can help detect heart damage caused by radiation therapy in patients with stage III lung cancer. If you're getting chemotherapy and radiation together, you may participate to help doctors find ways to reduce heart risks.
Indianapolis, IndianaAges 18 years+ - NCT07755020Recruiting
Blood test using new chip to find and monitor lung cancer
This study tests a new chip that may detect lung cancer from a blood sample. It will compare blood from people with lung cancer and people without, possibly helping to find or monitor the disease in the future.
TaichungAges 18 years+ - NCT07747337Recruiting
Lung transplant recovery study
This study looks at how your breathing muscles and leg muscles work before and after a lung transplant. It may help doctors understand how to improve recovery and physical function after surgery.
Gainesville, FloridaAges 18 years+ - NCT07744698RecruitingPhase 4
Maintenance therapy for advanced lung cancer
This trial tests a pill form of chemotherapy (oral paclitaxel) combined with an immunotherapy drug to keep advanced lung cancer from growing after initial treatment. It may help patients whose cancer was controlled with first-line therapy.
Hefei, AnhuiAges 18–75 - NCT07711691Recruiting
Lung cancer screening study for current/former smokers
This study aims to help people who qualify for lung cancer screening actually get screened. It tests a program to remind and support you to schedule a low-dose CT scan.
Anaheim, CaliforniaAges 50–80 - NCT07708870Recruiting
Nurse-led support for older adults with advanced lung cancer
This study tests a nurse-led support program for older adults (65+) with advanced lung cancer and their main family caregiver. The goal is to see if special help from a nurse can improve quality of life for both you and your caregiver.
Taipei, TaipeiAges 18 years+ - NCT07682610Recruiting
Improving lung cancer screening in Kentucky clinics
This study works with healthcare teams to improve how lung cancer screening is done. It uses surveys and feedback to find better ways to help patients get screened.
Ashland, KentuckyAges 18–100 - NCT07681245Recruiting
Real-time laser imaging for lung tissue during surgery
This study tests a new laser imaging device that works with artificial intelligence to quickly analyze lung tissue during surgery. The goal is to see if it can give as accurate results as the standard method, which could help surgeons make faster decisions during the operation.
Shanghai, Shanghai MunicipalityAges 18–90 - NCT07680764RecruitingPhase 2
Imzokitug plus pumitamig and chemo for first-line advanced lung cancer
This trial tests a new combination of drugs (imzokitug, pumitamig, and platinum-doublet chemotherapy) as a first treatment for advanced or metastatic non-small cell lung cancer that has not spread to the brain. The goal is to see if adding imzokitug makes the standard treatment work better.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06667154RecruitingPhase 2
Low-dose nivolumab plus chemo for early lung cancer
This trial tests a lower dose of the immunotherapy drug nivolumab (Opdivo) combined with standard chemotherapy before surgery for patients with early-stage non-small cell lung cancer (NSCLC). The goal is to see if this combination shrinks the tumor and improves outcomes with fewer side effects.
São José do Rio Preto, São PauloAges 18 years+ - NCT07673237Recruiting
Remote monitoring for interstitial lung disease
This study tests whether using remote monitoring devices and apps at home can help track your lung health between clinic visits. It may help you stay connected with your care team and catch changes sooner.
San Francisco, CaliforniaAges 18 years+ - NCT07649629Recruiting
Blood test to help diagnose advanced lung cancer
This study tests whether a blood test (liquid biopsy) can help doctors better understand your lung cancer and plan your treatment. You'll have a blood sample taken alongside standard biopsies to see if the blood test provides useful information about your cancer.
Roma, RMAges 18 years+ - NCT07633184Recruiting
Lung Ultrasound to Predict Breathing Problems in Premature Babies
This study uses ultrasound images of the lungs to see if doctors can predict which very premature babies will develop bronchopulmonary dysplasia (BPD)—a chronic lung condition common in extremely premature infants. The goal is to identify at-risk babies early so they can receive targeted treatment.
ModenaAges Up to 7 months - NCT07632365RecruitingPhase 1/Phase 2
Immunotherapy plus chemoradiation for inoperable stage III lung cancer
This trial tests a new combination of immunotherapy and chemotherapy before and after standard chemoradiation for patients with stage III lung cancer that cannot be surgically removed. The goal is to see if this approach improves outcomes compared to chemoradiation alone.
Shanghai, XuhuiAges 18 years+
Hear when a new Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for lung?
- Yes. Clin2 currently lists 2,833 recruiting lung studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a lung trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a lung trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.